U.S. flag

An official website of the United States government

NM_000642.3(AGL):c.2522C>T (p.Ser841Phe) AND AGL-related disorder

Germline classification:
Benign (1 submission)
Last evaluated:
Aug 24, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003891858.2

Allele description [Variation Report for NM_000642.3(AGL):c.2522C>T (p.Ser841Phe)]

NM_000642.3(AGL):c.2522C>T (p.Ser841Phe)

Gene:
AGL:amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p21.2
Genomic location:
Preferred name:
NM_000642.3(AGL):c.2522C>T (p.Ser841Phe)
HGVS:
  • NC_000001.11:g.99884427C>T
  • NG_012865.1:g.39344C>T
  • NM_000028.3:c.2522C>T
  • NM_000642.3:c.2522C>TMANE SELECT
  • NM_000643.3:c.2522C>T
  • NM_000644.3:c.2522C>T
  • NM_000646.3:c.2474C>T
  • NM_001425325.1:c.2522C>T
  • NM_001425326.1:c.2522C>T
  • NM_001425327.1:c.2321C>T
  • NM_001425328.1:c.2318C>T
  • NM_001425329.1:c.2318C>T
  • NM_001425332.1:c.2144C>T
  • NP_000019.2:p.Ser841Phe
  • NP_000019.2:p.Ser841Phe
  • NP_000633.2:p.Ser841Phe
  • NP_000634.2:p.Ser841Phe
  • NP_000634.2:p.Ser841Phe
  • NP_000635.2:p.Ser841Phe
  • NP_000635.2:p.Ser841Phe
  • NP_000637.2:p.Ser825Phe
  • NP_000637.2:p.Ser825Phe
  • NP_001412254.1:p.Ser841Phe
  • NP_001412255.1:p.Ser841Phe
  • NP_001412256.1:p.Ser774Phe
  • NP_001412257.1:p.Ser773Phe
  • NP_001412258.1:p.Ser773Phe
  • NP_001412261.1:p.Ser715Phe
  • NC_000001.10:g.100349983C>T
  • NM_000028.2:c.2522C>T
  • NM_000642.2:c.2522C>T
  • NM_000643.2:c.2522C>T
  • NM_000644.2:c.2522C>T
  • NM_000646.2:c.2474C>T
Protein change:
S715F
Links:
dbSNP: rs150441555
NCBI 1000 Genomes Browser:
rs150441555
Molecular consequence:
  • NM_000028.3:c.2522C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_000642.3:c.2522C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_000643.3:c.2522C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_000644.3:c.2522C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_000646.3:c.2474C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001425325.1:c.2522C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001425326.1:c.2522C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001425327.1:c.2321C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001425328.1:c.2318C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001425329.1:c.2318C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001425332.1:c.2144C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
AGL-related disorder
Synonyms:
AGL-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000305383PreventionGenetics, part of Exact Sciences
no assertion criteria provided
Benign
(Aug 24, 2019)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV000305383.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024